Poster Abstracts

3203 Isolated bulbar palsy variant of amyotrophic lateral sclerosis (ALS) in a patient with a pathogenic superoxide dismutase 1 (SOD1) mutation

Abstract

Background SOD1 mutations are the second most commonly implicated genetic cause of ALS. Many SOD1 variants have been identified, with few known to be linked to a defined clinical phenotype. 88% of patients with mutations in SOD1 are diagnosed with limb-onset disease. Only 2% of SOD1 patients are diagnosed with bulbar onset disease, which usually confers a significantly poorer prognosis.

Isolated bulbar palsy is a rare variant of ALS, characterised by symptoms confined to the bulbar region for a prolonged period of time, with relative sparing of the limbs. It comparatively confers a significantly better prognosis.

We describe a case of isolated bulbar palsy in a patient with ALS due to a SOD1 mutation (A-G, H43R).

Cases After initial presentation with mild dysarthria and hypophonia, a 36 year-old female was diagnosed with ALS. Her condition remained isolated until 4 years into her disease, when she noticed mild impairment of dexterity in her upper limbs. She remains asymptomatic from a respiratory perspective, and her weight has been stable, without dysphagia since her initial diagnosis with ALS.

At the most recent review 14 years post-diagnosis, there was mild to moderate dysarthria with hypophonia. Limb examination revealed mild weakness of her upper limbs, in a distal pattern.

Discussion ALS is a heterogeneous disease. While ALS represents a universally fatal condition, with a typical lifespan of 2–3 years, rare SOD1 variants may exhibit unexpected disease trajectories, which may confound approaches in the advent of antisense oligonucleotide therapy.

Article metrics
Altmetric data not available for this article.
Dimensionsopen-url